Doximity Inc. (NYSE:DOCS) faces a leadership shift as Chief Financial Officer Anna Bryson steps down following the February quarter. Despite the change, analysts express confidence, with Raymond James upholding a ‘strong buy’ rating and a $40 target price.
Interim Leadership and Guidance Reaffirmed
The company appoints Siddharth Sitaram, its Chief Accounting Officer, to serve as interim principal financial officer until a permanent replacement arrives. Doximity reaffirms its guidance for the fourth quarter and full fiscal year ending March 31, 2026.
Executives anticipate higher revenue from its major job postings platform, which generates about 90% of annual revenue over the past 12 months, fueled by a robust job market. More details on the CFO search will emerge during the next earnings report.
Analyst Confidence Persists
Brian Peterson, an analyst at Raymond James, highlights the smooth transition. “Doximity executes well-structured leadership changes,” Peterson states. He expresses faith in Sitaram’s oversight of financial operations and the company’s overall framework.
No significant alterations to guidance are expected. Shares have surged 63% over the past six months but show recent volatility, trading around $23.97 against a fair value estimate of $36.42.
Recent Analyst Adjustments
Leerink Partners maintains a positive outlook, lifting its price target to $34 and assigning an ‘Outperform’ rating.
Truist Securities shifts its stance from ‘Buy’ to ‘Hold’ due to valuation concerns, setting a $29 target.
BofA Securities stays optimistic on the recent OpenEvidence acquisition, adjusting the target from $56 to $47 while retaining a ‘Buy’ rating.
Evercore ISI downgrades from ‘Outperform’ to ‘In Line’ amid neutral sector concerns, targeting $25.
These updates underscore keen interest ahead of Doximity’s next earnings, reflecting the company’s momentum in healthcare networking.
